(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FINASTERIDE MAINTENANCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FINASTERIDE MAINTENANCE

ST13

US500000076349437

Class

42

Filing

76349437

Registration

2763434

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

03/29/2023

Trademark type

Word

Nice classes

42

Filing date

12/14/2001

Registration date

09/16/2003

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/29/2023

Last transaction

03/29/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/18/1994

First use in commerce

04/18/1994

Drawing code

1

Owner type

03

Owner location

Los Angeles, CA

Examiner

CASE, LEIGH

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

ROBERT LEROY LEIBOWITZ, M.D.

Representatives

ROBERT LEROY LEIBOWITZ, M.D.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical servicesproviding medical information and treatment strategies using specific pharmaceutical preparations for the treatment and management of all stages of prostate cancer

Publications

History of USPTO decisions and trademark events.

25 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/29/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

03/29/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/29/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/29/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

09/16/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED

02/16/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/16/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/16/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/15/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

01/28/2013

PLGL

ASSIGNED TO PARALEGAL

03/19/2009

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/19/2009

E815

TEAS SECTION 8 & 15 RECEIVED

03/17/2009

CFIT

CASE FILE IN TICRS

07/03/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

09/16/2003

PUBO

PUBLISHED FOR OPPOSITION

06/24/2003

NPUB

NOTICE OF PUBLICATION

06/04/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/28/2003

PETG

PETITION TO REVIVE-GRANTED

03/13/2003

PETR

PETITION TO REVIVE-RECEIVED

01/27/2003

MAIL

PAPER RECEIVED

01/27/2003

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

11/27/2002

DOCK

ASSIGNED TO EXAMINER

10/17/2002

CNRT

NON-FINAL ACTION MAILED

03/11/2002

DOCK

ASSIGNED TO EXAMINER

03/06/2002

Continuous trademark protection

Get notified about every new filing that threatens FINASTERIDE MAINTENANCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.